Monitoring patients with celiac disease on gluten free diet: different outcomes comparing three tissue transglutaminase IgA assays.
A H Leontine MulderDaan A R CastelijnPieter van der PolMarloes VermeerJolien C HollanderTietie KuiperCaroline BijnensHetty J BontkesJan G M C DamoiseauxPublished in: Clinical chemistry and laboratory medicine (2023)
Normalization of tTG-IgA in patients on GFD depends on the assay used. Both CLIA appear to be more sensitive in detecting suboptimal treatment response in CD-indicated by elevated i-FABP - when applying the manufacturer's recommended cut-off for the diagnosis of CD.